These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27499448)

  • 1. Docosahexaenoic acid supplementation (DHA) and the return on investment for pregnancy outcomes.
    Shireman TI; Kerling EH; Gajewski BJ; Colombo J; Carlson SE
    Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():8-10. PubMed ID: 27499448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials.
    Yelland LN; Gajewski BJ; Colombo J; Gibson RA; Makrides M; Carlson SE
    Prostaglandins Leukot Essent Fatty Acids; 2016 Sep; 112():44-9. PubMed ID: 27637340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Kansas University DHA Outcomes Study (KUDOS) clinical trial: long-term behavioral follow-up of the effects of prenatal DHA supplementation.
    Colombo J; Shaddy DJ; Gustafson K; Gajewski BJ; Thodosoff JM; Kerling E; Carlson SE
    Am J Clin Nutr; 2019 May; 109(5):1380-1392. PubMed ID: 31004139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol.
    Carlson SE; Gajewski BJ; Valentine CJ; Rogers LK; Weiner CP; DeFranco EA; Buhimschi CS
    BMC Pregnancy Childbirth; 2017 Feb; 17(1):62. PubMed ID: 28193189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher-Dose DHA Supplementation Modulates Immune Responses in Pregnancy and Is Associated with Decreased Preterm Birth.
    Valentine CJ; Khan AQ; Brown AR; Sands SA; Defranco EA; Gajewski BJ; Carlson SE; Reber KM; Rogers LK
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of hospital cost outcome of DHA-rich fish-oil supplementation in pregnancy: Evidence from a randomized controlled trial.
    Ahmed S; Makrides M; Sim N; McPhee A; Quinlivan J; Gibson R; Umberger W
    Prostaglandins Leukot Essent Fatty Acids; 2015 Dec; 102-103():5-11. PubMed ID: 26432510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHA supplementation and pregnancy outcomes.
    Carlson SE; Colombo J; Gajewski BJ; Gustafson KM; Mundy D; Yeast J; Georgieff MK; Markley LA; Kerling EH; Shaddy DJ
    Am J Clin Nutr; 2013 Apr; 97(4):808-15. PubMed ID: 23426033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationship between docosahexaenoic acid (DHA) intake and lower rates of early preterm birth, low birth weight and very low birth weight.
    Carlson SE; Gajewski BJ; Alhayek S; Colombo J; Kerling EH; Gustafson KM
    Prostaglandins Leukot Essent Fatty Acids; 2018 Nov; 138():1-5. PubMed ID: 30392575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal docosahexaenoic acid supplementation and fetal accretion.
    Montgomery C; Speake BK; Cameron A; Sattar N; Weaver LT
    Br J Nutr; 2003 Jul; 90(1):135-45. PubMed ID: 12844385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal DHA supplementation and infant attention.
    Colombo J; Gustafson KM; Gajewski BJ; Shaddy DJ; Kerling EH; Thodosoff JM; Doty T; Brez CC; Carlson SE
    Pediatr Res; 2016 Nov; 80(5):656-662. PubMed ID: 27362506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Prenatal Docosahexaenoic Acid Supplementation on Blood Pressure in Children With Overweight Condition or Obesity: A Secondary Analysis of a Randomized Clinical Trial.
    Kerling EH; Hilton JM; Thodosoff JM; Wick J; Colombo J; Carlson SE
    JAMA Netw Open; 2019 Feb; 2(2):e190088. PubMed ID: 30794304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico.
    Ramakrishnan U; Stein AD; Parra-Cabrera S; Wang M; Imhoff-Kunsch B; Juárez-Márquez S; Rivera J; Martorell R
    Food Nutr Bull; 2010 Jun; 31(2 Suppl):S108-16. PubMed ID: 20715595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Micronutrients and Docosahexaenoic Acid Supplementation during Pregnancy: A Randomized Controlled Study.
    Massari M; Novielli C; Mandò C; Di Francesco S; Della Porta M; Cazzola R; Panteghini M; Savasi V; Maggini S; Schaefer E; Cetin I
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma oxylipins and unesterified precursor fatty acids are altered by DHA supplementation in pregnancy: Can they help predict risk of preterm birth?
    Ramsden CE; Makrides M; Yuan ZX; Horowitz MS; Zamora D; Yelland LN; Best K; Jensen J; Taha AY; Gibson RA
    Prostaglandins Leukot Essent Fatty Acids; 2020 Feb; 153():102041. PubMed ID: 31931275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial.
    Krauss-Etschmann S; Shadid R; Campoy C; Hoster E; Demmelmair H; Jiménez M; Gil A; Rivero M; Veszprémi B; Decsi T; Koletzko BV;
    Am J Clin Nutr; 2007 May; 85(5):1392-400. PubMed ID: 17490978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid (DHA) intake estimated from a 7-question survey identifies pregnancies most likely to benefit from high-dose DHA supplementation.
    Christifano DN; Crawford SA; Lee G; Brown AR; Camargo JT; Kerling EH; Gajewski BJ; Valentine CJ; Gustafson KM; DeFranco EA; Carlson SE
    Clin Nutr ESPEN; 2023 Feb; 53():93-99. PubMed ID: 36657936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current information and Asian perspectives on long-chain polyunsaturated fatty acids in pregnancy, lactation, and infancy: systematic review and practice recommendations from an early nutrition academy workshop.
    Koletzko B; Boey CC; Campoy C; Carlson SE; Chang N; Guillermo-Tuazon MA; Joshi S; Prell C; Quak SH; Sjarif DR; Su Y; Supapannachart S; Yamashiro Y; Osendarp SJ
    Ann Nutr Metab; 2014; 65(1):49-80. PubMed ID: 25227906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine distribution in mothers and breastfed children after omega-3 LCPUFAs supplementation during the last trimester of pregnancy and the lactation period: A randomized, controlled trial.
    Rodriguez-Santana Y; Ochoa JJ; Lara-Villoslada F; Kajarabille N; Saavedra-Santana P; Hurtado JA; Peña M; Diaz-Castro J; Sebastian-Garcia I; Machin-Martin E; Villanueva M; Ramirez-Garcia O; Peña-Quintana L
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():32-38. PubMed ID: 29031393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings.
    Sanjurjo P; Ruiz-Sanz JI; Jimeno P; Aldámiz-Echevarría L; Aquino L; Matorras R; Esteban J; Banqué M
    J Perinat Med; 2004; 32(2):132-6. PubMed ID: 15085888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHA, nutrient intake, and maternal characteristics as predictors of pregnancy outcomes in a randomised clinical trial of DHA supplementation.
    Wang Y; Gajewski BJ; Valentine CJ; Crawford SA; Brown AR; Mudaranthakam DP; Camargo JT; Carlson SE
    Clin Nutr; 2023 Nov; 42(11):2229-2240. PubMed ID: 37806075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.